Trial Profile
Peramivir vs rimantadine vs peramivir + rimantadine in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Oct 2011
Price :
$35
*
At a glance
- Drugs Peramivir (Primary) ; Rimantadine (Primary)
- Indications Influenza virus infections
- Focus Pharmacokinetics
- Sponsors BioCryst Pharmaceuticals
- 29 Sep 2011 Results published in the Journal of Clinical Pharmacology.
- 05 Nov 2010 New trial record.